Psychedelic Medical Start-Up Awakn Life Sciences Enters the UK Market with Dr. Ben Sessa
Awakn to acquire controlling interest in Dr. Ben Sessa’s clinical operations Awakn announces today that it has signed a binding investment agreement to acquire a controlling interest in Mandala Therapy…